1.
Haidar Mohammed Hussein, Ali Abdulhussein Kasim. Correlation of the Complement Decay Accelerating Factor, Tumour Necrosis Factors-alpha, and Interleukin-1 Beta with the Response to Rituximab in Rheumatoid Arthritis Patients. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2025 Feb. 15 [cited 2025 Feb. 22];33((4SI):222-9. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3657